Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
CPSC Recall1 injuries · 2023-03-16 · 23154
Hazards
The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
Biohaven Pharmaceuticals Inc., of New Haven, Conn.; Pfizer Inc., of New York
Retailer(s)
Pharmacies nationwide as a prescribed medicine from December 2021 through March 2023. The prices of the product varied based on health insurance terms and other factors.
Country of manufacture
United States
Description
This recall involves prescription drugs Nurtec ODT 75 mg orally disintegrating tablets sold in cartons containing one blister card of 8 tablets. The tablets are in a non-child resistant blister card packaged in a carton that includes the name of the product, dosage strength, expiration date. The dosage strength and expiration date are printed or stamped on the blister card. The recall includes the following: Product Description NDC Number Expiration Date Nurtec® ODT (rimegepant) 75mg 8-Unit Dose blister pack 72618-3000-2 All dates through 6/2026